Intuitive Corp (ISRG) Value Adjusted for Debt and Cash

Official company branding of Intuitive Corp (ISRG)

Intuitive Surgical (ISRG) maintains its leadership in robotic surgery, generating revenue through consistent component sales and the deployment of new systems. Stable demand for procedures renders the company independent of economic crises. The stock price history shows that the Enterprise Value is 152614.50. The business relies on the volume of scheduled interventions, hospital capital expenditures, the certification of new devices, and physician qualifications.

ISRG (Intuitive Surgical Inc) Total Company Value history from 11/23/2025 to 10/27/2026

ISRG (Intuitive Surgical): analytical breakdowns and indicator data

- price and consensus price forecast:
Market Chart Intuitive Surgical, Inc.|ISRG - Price Target Chart
- market capitalization data:
Market Value Intuitive Surgical|ISRG - Enterprise Value
- book capitalization data:
Book Value of One Share Intuitive Surgical|ISRG - Company Book Value|Market Cap to Net Assets Ratio intuitive.com|ISRG - Company Total Assets
- debt and liquidity data:
Debt to Capital Intuitive Surgical|ISRG - Long-Term Debt to Capital|Short-Term Debt to Capital Ratio intuitive.com|ISRG - Company Aggregate Debts|Debts to Net Assets Intuitive Surgical
General company analysis:ISRG (Intuitive Surgical, Inc.)
Original product of Intuitive Surgical, Inc.

Enterprise Value (EV) combines market capitalization and net debt, allowing an investor to assess the actual cost of acquiring a business regardless of its liquidity. For Intuitive Surgical (ISRG), the current EV level reflects a premium for its technological monopoly and ecosystem management efficiency, confirming that the asset's market price is justified by its fundamental ability to generate sustainable cash flows.

Competitor analysis for Intuitive Surgical

Danaher Corporation - Company Buyout Price|Total Company Value Becton, Dickinson and Company (BDX)|STE - Value Adjusted for Debt and Cash|Enterprise Value WST (West Pharmaceutical Services)|BAX (baxter.com) - Full Takeover Company Value|Total Company Value MASI|Real Price to Acquire Entire Company Stevanato Group SpA|Teleflex Inc - Enterprise Value|Total Enterprise Value Merit Medical Corp (MMSI)|NVST - Enterprise Value|Business Value icumed.com ICUI|Enterprise Value XRAY (Dentsply Sirona)|LMAT - Company Buyout Price|ATRC (AtriCure Corp) - Enterprise Value|STAAR Surgical Co (STAA) - Real Price to Acquire Entire Company|NAGE (ChromaDex Corp) - Enterprise Value|Enterprise Value ZIMV|Total Company Value AngioDynamics (ANGO)|Total Company Value Cerus Corp. CERS|Real Price to Acquire Entire Company Alpha Teknova Inc|Value Adjusted for Debt and Cash Monogram Orthopedics Inc. MGRM|Enterprise Value STSS (Sharps Tech)|INFU: Company Buyout Price|Total Company Value Utah Medical Products, Inc.|KRMD (KORU Medical) - Business Value|NYXH: Total Company Value|Company Buyout Price Microbot Medical, Inc (MBOT)|Real Price to Acquire Entire Company Pro-Dex, Inc.|Aggregate Business Value ZTEK (zentek.com)|Total Company Value Elutia|MLSS - Value Adjusted for Debt and Cash|NEXGEL, Inc - Real Price to Acquire Entire Company|RVP: Enterprise Value|HBIO (Harvard Bioscience) - Total Company Value|femasys.com (FEMY) - Real Price to Acquire Entire Company|Enterprise Value MHUA (Meihua Medical Technologies)|Total Enterprise Value POAI|Total Company Value Callan JMB Inc CJMB|Business Value Atrion Corporation Inc. ATRI|Real Price to Acquire Entire Company NeuroMetrix, Inc. (NURO)